Study Name: A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepati
28 locations found
- Study Name Unavailable
Location: Birmingham, Alabama
- Study Name Unavailable
Location: San Diego, California
- Study Name Unavailable
Location: Englewood, Colorado
- Study Name Unavailable
Location: Bradenton, Florida
- Study Name Unavailable
Location: Jacksonville, Florida
- Study Name Unavailable
Location: Tampa, Florida
- Study Name Unavailable
Location: Marietta, Georgia
- Study Name Unavailable
Location: Chicago, Illinois
- Study Name Unavailable
Location: Indianapolis, Indiana
- Study Name Unavailable
Location: Boston, Massachusetts
- Study Name Unavailable
Location: Detroit, Michigan
- Study Name Unavailable
Location: Lebanon, New Hampshire
- Study Name Unavailable
Location: Egg Harbor Township, New Jersey
- Study Name Unavailable
Location: Manhasset, New York
- Study Name Unavailable
Location: New York, New York
- Study Name Unavailable
Location: Rochester, New York
- Study Name Unavailable
Location: Asheville, North Carolina
- Study Name Unavailable
Location: Charlotte, North Carolina
- Study Name Unavailable
Location: Durham, North Carolina
- Study Name Unavailable
Location: Cincinnati, Ohio
- Study Name Unavailable
Location: Providence, Rhode Island
- Study Name Unavailable
Location: Germantown, Tennessee
- Study Name Unavailable
Location: Arlington, Texas
- Study Name Unavailable
Location: Houston, Texas
- Study Name Unavailable
Location: San Antonio, Texas
- Study Name Unavailable
Location: Norfolk, Virginia
- Study Name Unavailable
Location: Madison, Wisconsin
- Study Name Unavailable
Location: Milwaukee, Wisconsin
|